Compare INDRAPRASTHA MEDICAL with MALAR HOSP. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs FORTIS MALAR - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL FORTIS MALAR INDRAPRASTHA MEDICAL/
FORTIS MALAR
 
P/E (TTM) x 16.0 -18.9 - View Chart
P/BV x 2.5 1.3 187.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 INDRAPRASTHA MEDICAL   FORTIS MALAR
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-21
FORTIS MALAR
Mar-21
INDRAPRASTHA MEDICAL/
FORTIS MALAR
5-Yr Chart
Click to enlarge
High Rs7065 107.9%   
Low Rs3139 81.3%   
Sales per share (Unadj.) Rs66.936.9 181.1%  
Earnings per share (Unadj.) Rs0.3-4.2 -6.1%  
Cash flow per share (Unadj.) Rs3.92.7 145.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs29.847.4 62.8%  
Shares outstanding (eoy) m91.6718.74 489.2%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.81.4 54.1%   
Avg P/E ratio x199.2-12.3 -1,619.0%  
P/CF ratio (eoy) x13.019.3 67.3%  
Price / Book Value ratio x1.71.1 155.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m4,639968 479.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1,977183 1,083.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,134692 885.8%  
Other income Rs m783 8.2%   
Total revenues Rs m6,141775 792.4%   
Gross profit Rs m4035 7,865.2%  
Depreciation Rs m333129 258.8%   
Interest Rs m3372 46.3%   
Profit before tax Rs m43-113 -37.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20-34 -56.9%   
Profit after tax Rs m23-79 -29.6%  
Gross profit margin %6.60.7 888.4%  
Effective tax rate %45.730.4 150.1%   
Net profit margin %0.4-11.4 -3.3%  
BALANCE SHEET DATA
Current assets Rs m1,414600 235.8%   
Current liabilities Rs m1,159247 469.6%   
Net working cap to sales %4.251.0 8.2%  
Current ratio x1.22.4 50.2%  
Inventory Days Days2168 1.4%  
Debtors Days Days40110 36.4%  
Net fixed assets Rs m2,9051,007 288.6%   
Share capital Rs m917188 488.7%   
"Free" reserves Rs m1,811700 258.7%   
Net worth Rs m2,728887 307.3%   
Long term debt Rs m00-   
Total assets Rs m4,3201,606 268.9%  
Interest coverage x2.3-0.6 -400.1%   
Debt to equity ratio x00-  
Sales to assets ratio x1.40.4 329.4%   
Return on assets %1.3-0.4 -314.5%  
Return on equity %0.9-8.9 -9.6%  
Return on capital %2.8-4.6 -60.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6209 6,864.7%   
Fx outflow Rs m522 2,622.1%   
Net fx Rs m5687 8,063.9%   
CASH FLOW
From Operations Rs m279-9 -3,232.7%  
From Investments Rs m-202-275 73.3%  
From Financial Activity Rs m-31-72 43.4%  
Net Cashflow Rs m46-356 -12.9%  

Share Holding

Indian Promoters % 49.4 62.7 78.8%  
Foreign collaborators % 1.6 0.0 -  
Indian inst/Mut Fund % 0.1 0.1 71.4%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 37.3 131.4%  
Shareholders   58,001 9,422 615.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   DR. LAL PATHLABS  DR LALCHANDANI LABS  VIJAYA DIAGNOSTIC  CONSTRONICS INFRA  DHANVANTRI JEEV  



Today's Market

Sensex, Nifty Continue Downtrend to End Lower for 4th Day; Metal & IT Stocks Drag(Closing)

After opening the day on a positive note, Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Oct 22, 2021 (Close)

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL 8-QTR ANALYSIS

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS